SALT LAKE CITY March 09, 2023, APEX Biologix, a leading regenerative medicine device company that specializes in the development of advanced patient therapies, announced today it has entered into a know-how license agreement with Mayo Clinic to jointly develop new regenerative medicine products.

APEX Biologix, a leader in the regenerative medicine industry, announced today the addition of a new visionary executive to the company. Jim Rogers brings more than 20 years of creation and business development in the medical device industry to the growing team at APEX Biologix.